Biocept BIOC
$ 0.43
-13.05%
Quarterly report 2023-Q2
added 08-14-2023
Country |
USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Michael Nall |
Employees in the company |
88 |
Shares |
17 M |
Market Cap[1] |
$ 7.29 M |
EBITDA (LTM) |
$ -21.8 M |
P/E (LTM) |
-0.05 |
P/S (LTM) |
1.47 |
EPS (LTM) |
-22.06 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.